Histamine H₃ receptor (H₃R)

The histamine H₃ receptor is a G protein-coupled receptor that is primarily expressed in the central nervous system, especially in the cortex and subcortex. It acts both as a presynaptic autoreceptor on histaminergic neurons, regulating histamine release through negative feedback, and as a heteroreceptor on non-histaminergic neurons, modulating the release of other neurotransmitters including dopamine, acetylcholine, norepinephrine, serotonin, and glutamate. The receptor is distinguished by multiple isoforms due to alternative splicing. Its physiological roles include control of wakefulness, cognition, appetite, and other behavioral processes. The H₃ receptor has drawn significant interest for therapeutic intervention in diseases such as sleep disorders, cognitive impairment, ADHD, schizophrenia, neurodegenerative diseases, obesity, and addiction. Drugs targeting H₃R include agonists, antagonists, and inverse agonists, with pitolisant currently approved for narcolepsy. The receptor's pharmacology is complex due to constitutive activity, genetic variation, and isoform diversity, which present challenges for drug development and clinical application.

Other names

H₃RH3 receptorHRH3Occasionally "histamine receptor H3"

Antagonists/inverse agonists block H₃R to increase histamine and other neurotransmitter release, leading to stimulant and cognitive enhancing effects Agonists activate H₃R, inhibiting histamine and other neurotransmitter release Modulation of neurotransmitter systems can impact downstream pathways relevant for cognition, sleep, and other CNS functions